Sonoma Biotherapeutics

Sonoma Biotherapeutics

Best-in-class regulatory T cell therapy, delivering long-lasting, highly effective, curative treatments across a spectrum of autoimmune and degenerative diseases. Learn more

Launch date
Employees
Market cap
-
Enterprise valuation
$1.1—1.6b (Dealroom.co estimates Aug 2021.)
San Francisco California (HQ)
Authorizing premium user...